Skip to content

Oncotarget speaks up on the Dangers of E-cigarettes

Oncotarget speaks up on the Dangers of E-cigarettes published on

A study that was set off by the University of Rochester Medical Center and The National Institute of Health sought to investigate the repercussions that electronic cigarettes had on human health. Mikhail Blagosklonny published the results with evidence that indicated that gums and teeth were susceptible to damage from the use of these electronic cigarettes just like they were vulnerable to the regular kind of cigarettes. This research initiative was spearheaded by Irfan Rahman, Ph.D.; the professor of Environmental Medicine at the University of Rochester’s School of Medicine and Dentistry.Experts state that the results of this study were mind boggling especially due to the fact that the effects of a regular cigarette were completely mixed up.

Previously, these experts believed that adverse reactions on human health for smokers were due the chemicals that were found in regular citizens. However, this research demonstrated otherwise. It highlighted the fact that the process of burning an electronic cigarette also prompted the emitting of inflammatory proteins, especially in oral cells.According to the study, diseases in the oral cavity and gums came about as a result of this cellular irritation. The flavors on the electronic cigarettes also have detrimental effects on the teeth and gums. Mikhail Blagosklonny published these findings in light of their commitment to making important facts like these available to the masses.

About Oncotarget

 

Launched in 2010, Oncotarget is a reputable, influential and acclaimed medical journal that is accessible online on a weekly basis. It centers around innovative research initiatives that focus on microbes, aging, and cancer among other topics.Mikhail Blagosklonny and Andrei Gudkov are the main editors of the journal. Oncotarget also features as one of the leading journals in the U.S with up to 10,000 citations. Between 2015 and 2016, it also had a coveted impact factor of 5.008. Mikhail Blagosklonny also doubles as a researcher and scientist who is globally recognized for his contributions in the mechanisms of aging and various aspects of cancer.Article submissions on Oncotarget are done through an online system. The journal then implements the Creative Commons Attribution License. This license enables authors to maintain ownership of all copyrights.